Emergent BioSolutions (EBS)

14.56 +0.13  +0.90%  May 17, 8:00PM
Add to Watchlists Create an Alert

Emergent BioSolutions Cash from Investing TTM:

-39.20M for March 31, 2013
View Full Chart

Emergent BioSolutions Cash from Investing TTM Chart

    Emergent BioSolutions Historical Cash from Investing TTM Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 -39.20M
    Dec. 31, 2012 -40.11M
    Sept. 30, 2012 -45.55M
    June 30, 2012 -51.34M
    March 31, 2012 -49.82M
    Dec. 31, 2011 -53.96M
    Sept. 30, 2011 -45.04M
    June 30, 2011 -34.64M
    March 31, 2011 -31.17M
    Dec. 31, 2010 -23.46M
    Sept. 30, 2010 -32.95M
       
    June 30, 2010 -32.82M
    March 31, 2010 -33.56M
    Dec. 31, 2009 -33.29M
    Sept. 30, 2009 -18.72M
    June 30, 2009 -17.36M
    March 31, 2009 -25.14M
    Dec. 31, 2008 -30.81M
    Sept. 30, 2008 -29.24M
    June 30, 2008 -39.17M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro

    About Cash From Investing (TTM)

    Definition: Cash from Investing

    Learn More

    Get data for

    EBS Cash from Investing TTM Benchmarks

    Companies
    Arena Pharmaceuticals -2.171M
    China Biologic Products -26.75M
    Threshold Pharmaceuticals -61.53M

    EBS Cash from Investing TTM Rankings

    Overall 67th percentile
    2598 of 8007
    Sector 37th percentile
    426 of 685 in Healthcare
    Industry 30th percentile
    173 of 248 in Biotechnology

    EBS Cash from Investing TTM Range, Past 5 Years

    Minimum -53.96M Dec 2011
    Maximum -17.36M Jun 2009
    Average -35.37M